Volitionrx Valuation
| VNRX Stock | USD 0.70 0.09 11.39% |
Volitionrx is undervalued. Volitionrx has a current Real Value of $1.35 per share. The regular price of the company is $0.7. Our model measures the value of Volitionrx from inspecting the company fundamentals such as Return On Equity of -7.3, current valuation of 74.04 M, and Shares Owned By Insiders of 22.80 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Volitionrx's valuation include:
Price Book 38.4366 | Enterprise Value 74 M | Enterprise Value Ebitda (1.43) | Price Sales 66.7859 | Enterprise Value Revenue 57.5806 |
Undervalued
Today
Please note that Volitionrx's price fluctuation is extremely dangerous at this time. Calculation of the real value of Volitionrx is based on 3 months time horizon. Increasing Volitionrx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Volitionrx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Volitionrx Stock. However, Volitionrx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.7 | Real 1.35 | Target 3.42 | Hype 0.7 |
The intrinsic value of Volitionrx's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Volitionrx's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Volitionrx helps investors to forecast how Volitionrx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Volitionrx more accurately as focusing exclusively on Volitionrx's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Volitionrx's intrinsic value based on its ongoing forecasts of Volitionrx's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Volitionrx's closest peers.
Volitionrx Cash |
|
Volitionrx Valuation Trend
Analysing the historical paterns of Volitionrx's enterprise value and its market capitalization is a good way to estimate and gauge the value of Volitionrx over time and is usually enough for investors to make rational market timing decisions.
Volitionrx Total Value Analysis
Volitionrx is at this time projected to have valuation of 74.04 M with market capitalization of 65.22 M, debt of 5.86 M, and cash on hands of 16.42 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Volitionrx fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
74.04 M | 65.22 M | 5.86 M | 16.42 M |
Volitionrx Investor Information
About 23.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.36. Volitionrx had not issued any dividends in recent years. Based on the key measurements obtained from Volitionrx's financial statements, Volitionrx may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Volitionrx Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Volitionrx has an asset utilization ratio of 2.77 percent. This suggests that the Company is making $0.0277 for each dollar of assets. An increasing asset utilization means that Volitionrx is more efficient with each dollar of assets it utilizes for everyday operations.Volitionrx Ownership Allocation
Volitionrx shows a total of 92.66 Million outstanding shares. Volitionrx maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Volitionrx Profitability Analysis
The company reported the previous year's revenue of 775.3 K. Net Loss for the year was (35.32 M) with profit before overhead, payroll, taxes, and interest of 306.39 K.About Volitionrx Valuation
Our relative valuation model uses a comparative analysis of Volitionrx. We calculate exposure to Volitionrx's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Volitionrx's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -636.3 K | -604.5 K | |
| Pretax Profit Margin | (46.02) | (48.32) | |
| Operating Profit Margin | (46.42) | (48.74) | |
| Net Loss | (45.56) | (47.83) | |
| Gross Profit Margin | (2.59) | (2.72) |
Volitionrx Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 71.2 M |
Volitionrx Current Valuation Indicators
Valuation refers to the process of determining the present value of Volitionrx and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Volitionrx we look at many different elements of the entity such as Volitionrx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Volitionrx, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Volitionrx's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Volitionrx's worth.Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.